Leading manufacturer of pharmaceutical products to help address prevalence of iron deficiency in the region
April 29, 2015
Vifor Pharma, a company of the Galenica Group, a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency, has revealed its plans to expand its presence in the Middle East with the opening of its first office in the UAE. The leading company’s new office, which is located along Sheikh Zayed Road, was inaugurated today (April 29, 2015). The company is a global leader in the development, production and marketing of innovative products for the treatment of iron deficiency--with or without anaemia. The opening proves to be both timely and strategic as Vifor Pharma will play a significant role in the region’s continuous efforts to address iron deficiency in the region.
Medical specialists have defined iron deficiency as a frequently unrecognized and under-diagnosed condition that can add substantially to the burden of an underlying disease. Recent reports have shown that the prevalence of iron deficiency in Middle East countries is moderate to severe. The increased cases can be attributed to the Middle East’s ineffective iron fortification program, food interaction and hemoglobin application, which also act as anaemia indictors in these countries. Looking to help address this issue, Vifor Pharma is committed to support patients with iron deficiency anaemia by developing innovative medicines that improve their lives
“We remain highly upbeat with the opening of our first office in the Middle East region—allowing us to tap into a market that represents many potential opportunities for us,” said Myriam Hakim, Regional Director – GCC, Vifor Pharma. “Iron deficiency anaemia is a public health problem in the Middle East. As a global leader in the development, production and marketing of innovative products for the treatment of iron deficiency with or without anaemia, Vifor Pharma brings its commitment and vision to the Middle East—utilizing our medical expertise to make a difference in patient’s lives.”
Headquartered in Zurich, Vifor Pharma has a strong global presence with manufacturing sites in Switzerland and Portugal as well as a broad network of marketing affiliates and partners around the world. The company operates under four business units--Iron franchise; Vifor Fresenius Medical Care Renal Pharma Limited; Infectious Diseases / OTX and Consumer Healthcare.
